Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 906-912, April 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, S. M.
Right arrow Articles by Bryan, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, S. M.
Right arrow Articles by Bryan, G. T.

Carcinogenicity of Formic Acid 2-[4-(5-Nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss Mice1

S. M. Cohen2, E. Ertürk and George T. Bryan3

Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin 53706

Formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl] hydrazide was fed to 50 female 5-week-old Swiss mice at a dose of 0.1% by weight of diet for a total of 29 weeks, with a cumulative dose of 1.2 g/mouse/29 weeks. Because of acute toxicity of the chemical and cannibalization by other mice, only 22 of 50 mice survived to the end of feeding and were evaluated. Fifty-six control mice received control diet, and 44 survived and were evaluated.

Formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl] hydrazide appeared to be a strong carcinogenic (21/22) and leukemogenic (19/22) chemical in this animal species. The solid tumors induced included squamous cell and adenocarcinoma of the stomach (21/22), alveolar lung carcinomas (9/22), mammary adenocarcinomas (7/22), and single tumors of the uterus and skin. In the control mice, the following tumor incidences were found: generalized leukemias, 15/44; and lung, 1/44.

1 Supported in part by Grant CA-10341 from the National Cancer Institute, USPHS, and by a grant from the Wisconsin Division of the American Cancer Society.

2 Medical Scientist Trainee of the National Institute of General Medical Sciences, USPHS (GM-01932).

3 Career Development Awardee of the National Cancer Institute, USPHS. (1-K4-CA-8245-01A1).

Received 7/17/69. Accepted 9/10/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.